Table2_LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer.pdf
Triple negative breast cancer (TNBC) is a subtype of breast cancer with significant malignancy and poor prognosis but effective treatments are limited. Given the critical role of CDK4/6 in cell cycle and the apparent success of CDK4/6 inhibitors against certain cancer, this study attempted to utilize hydrophobic tagging technology to develop a CDK4/6 degrader against TNBC. We based on the chemical structure of the major metabolite of a clinically approved CDK4/6 inhibitor, abemaciclib, to synthesize three compounds and evaluated their in vitro cytotoxicity. LPM3770277 stood out as the most promising compound which was further confirmed by a series of binding and CDK4/6 degradation studies. LPM3770277 was able to bind to CDK4/6, and time-dependently and dose-dependently increased CDK4/6 protein degradation. Mechanistic study revealed that LPM3770277 exerted its CDK4/6 degradation effect via two machineries: proteasome and lysosome-promoted autophagy. Using in vivo TNBC xenograft cancer model, we found that LPM3770277 demonstrated superior anti-tumor efficacy and safety as compared to abemaciclib, although both compounds exerted similar effects on cell cycle arrest. In conclusion, this study for the first time developed and characterized a CDK4/6 degrader against TNBC using hydrophobic tags, which strongly suggests the viability of hydrophobic tags as a strategy to develop potential treatments against TNBC.
History
References
- https://doi.org//10.1200/JCO.2006.07.4658
- https://doi.org//10.1016/j.celrep.2018.12.013
- https://doi.org//10.1158/1078-0432.Ccr-17-0369
- https://doi.org//10.3389/fncel.2018.00126
- https://doi.org//10.1016/j.chembiol.2017.05.024
- https://doi.org//10.1126/science.1219021
- https://doi.org//10.1126/sciadv.abb2210
- https://doi.org//10.1146/annurev.biochem.78.081507.101607
- https://doi.org//10.1002/anie.201503720
- https://doi.org//10.3390/ijms18102093
- https://doi.org//10.1146/annurev-biochem-060208-092442
- https://doi.org//10.1053/j.seminoncol.2018.03.006
- https://doi.org//10.1038/nrd.2016.211
- https://doi.org//10.1172/Jci45014
- https://doi.org//10.1101/cshperspect.a004507
- https://doi.org//10.1021/acs.jnatprod.7b00857
- https://doi.org//10.1021/acs.jmedchem.5b00760
- https://doi.org//10.1038/nrclinonc.2016.26
- https://doi.org//10.4174/jkss.2011.80.5.301
- https://doi.org//10.1177/2058738418787991
- https://doi.org//10.1093/cvr/cvq217
- https://doi.org//10.1016/j.apsb.2019.08.001
- https://doi.org//10.1038/nrd2742
- https://doi.org//10.1002/hep.29781